Introduction of Geftistar 250mg Tablet
Geftistar 250mg Tablet helps to relieve the extreme pain and discomfort suffered by patients of breast or lung cancers. It slows down the production of cancer cells, thereby inhibiting the spread of the malignant tissues. It can be administered orally with or without food.
The dosage depends upon the medical history of the patient, health conditions and the response to the therapy.
The drug is contraindicated in patients who have suffered or are suffering from glaucoma, cardiac disorders, lungs or liver disorders or renal malfunctioning. Take proper medical help in case you are pregnant, planning a pregnancy any time soon or breastfeeding. You must also inform the doctor of any other prescription drugs that you may be taking, such as hormonal pills as oral contraceptives, or any dietary supplements as Geftistar 250mg Tablet may interact with the other drugs and cause a number of health complications. You must avoid alcohol consumption, smoking, tobacco or caffeine during the course of the treatment to avoid any further health complications.
There may be a number of side effects such as headaches, blurred vision, some nausea, and some allergic rashes on the skin. However there can be some adverse reactions as well. It is advised that even the slightest discomfort should be reported to the doctor immediately, in order to avoid complications.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.
Side Effects of Geftistar 250mg
- Nausea
- Rash
- Vomiting
- Weakness
- Loss Of Appetite
- Dry Skin
- Diarrhoea
- Stomatitis (Inflammation Of The Mouth)
How does Geftistar 250mg Works?
Geftistar 250mg Tablet is an anticancer agent which binds to the ATP binding site of the enzyme tyrosine kinase, an epidermal growth factor receptor (EGFR). This inhibits tyrosine kinase and prevents activation of Ras signal transduction cascade, preventing growth of malignant cells.
Reviews
There are no reviews yet.